Report Categories
View AllRecent Articles
View All
What DarkIris DKI management is focused on executing
How Taoping TAOP balances short term and long term focus Q2 2011 Below Expectations
The margin expansion playbook at Koss Corporation KOSS
The market opportunity XOMA XOMAO is chasing Consolidates 20260506
SpaceX Postpones Starship Launch Amid Anticipated RecordBreaking IPO
Knowledge Realty Trust Plans Rs 700 Crore Investment for 14 Million Sq Ft Office Development in Bengaluru
UKGulf Trade Deal Hailed as Monumental Achievement by Bahrain Minister
Wingstop Shares Slide 12 After Earnings Miss Estimates
China Urges APEC Cooperation as Commerce Minister Skips Meeting Due to Urgent Business
Indian Markets Edge Higher Financials Lead While Pharma Caps Gains Key Levels on Watch
FLG Q1 2026 Earnings EPS beats estimates as Flagstar delivers positive surprise
Grand Canyon Education LOPE Q1 2026 Earnings EPS Slightly Beats Estimates Shares Edge Higher
Harte Hanks HHS Q2 2025 Earnings Narrow Loss Reported as Stock Inches Higher
SSSSL Q1 2026 Earnings Massive EPS Surprise on Investment Gains Bond Price Edges Lower
Eikon Therapeutics Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline
Domo Inc Q1 2026 Earnings Beats EPS Estimates by Wide Margin
Qfin Holdings Surges 25 as Strong Volume Drives Breakout Above Key Levels
Centurion Acquisition Corp Warrant ALFUW Holds Steady at 014 as Trading Remains Rangebound
BioXcel Therapeutics BTAI Falls Further as Biotech Struggles to Hold Support
IRIDEX Corporation IRIX Holds Steady at 101 as Key Support and Resistance Levels Tighten
Drugs Made In America Acquisition II Corp Unit DMIIU Holds Steady Near Trust Value Amid Low Volatility
Compass Therapeutics Q1 2026 Earnings Narrowerthanexpected Loss Fuels Investor Optimism
STTK Q1 2026 Earnings Narrowerthanexpected loss highlights cost discipline amid prerevenue stage
MQ Q1 2026 Earnings Surprise Profitability as EPS Beats Estimates
Amphastar Pharmaceuticals AMPH Q1 2026 Earnings Significant EPS Miss Fails to Dampen Stock Sentiment
Upstream Bio UPB Q1 2026 Earnings NarrowerthanExpected Loss with No Revenue Yet
AVAH Q1 2026 Earnings EPS Surges Past Estimates Yet Stock Declines